Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Pharmacopsychiatry

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    May 2021
  1. SPOOV J, Bredbacka PE
    Failing Memory in Nonaffective Psychosis and Prolactin Response to 12.5 microg i.v. TRH.
    Pharmacopsychiatry. 2021 May 12. doi: 10.1055/a-1481-9058.
    PubMed     Abstract available

    February 2021
  2. SHI H, Guan XN, Liu DY, Zhu L, et al
    Sex-specific Association of Antipsychotic-induced Weight Gain and Treatment Response for Antipsychotic-Naive First Episode Schizophrenia Patients: A Prospective 8-week Longitudinal Study.
    Pharmacopsychiatry. 2021 Feb 24. doi: 10.1055/a-1353-6544.
    PubMed     Abstract available

    January 2021
  3. SAKURAI H, Yasui-Furukori N, Suzuki T, Uchida H, et al
    Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus.
    Pharmacopsychiatry. 2021 Jan 12. doi: 10.1055/a-1324-3517.
    PubMed     Abstract available

    December 2020
  4. GRUNDER G, Bauknecht P, Klingberg S, Leopold K, et al
    Treatment Goals for Patients with Schizophrenia - A Narrative Review of Physician and Patient Perspectives.
    Pharmacopsychiatry. 2020 Dec 8. doi: 10.1055/a-1298-4546.
    PubMed     Abstract available

    October 2020
  5. ZHANG T, Wang J, Xu L, Wei Y, et al
    Subtypes of Clinical High Risk for Psychosis that Predict Antipsychotic Effectiveness in Long-Term Remission.
    Pharmacopsychiatry. 2020 Oct 12. doi: 10.1055/a-1252-2942.
    PubMed     Abstract available

    August 2020
  6. WAGNER E, Oviedo-Salcedo T, Pelzer N, Strube W, et al
    Effects of Smoking Status on Remission and Metabolic and Cognitive Outcomes in Schizophrenia Patients Treated with Clozapine.
    Pharmacopsychiatry. 2020 Aug 5. doi: 10.1055/a-1208-0045.
    PubMed     Abstract available

    July 2020

  7. "Peter Muller Preis fur Forschung im Bereich Schizophrenie" in Hohe von 5.000euro.
    Pharmacopsychiatry. 2020;53:194.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.